These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19567032)

  • 1. [Investigating the relationship between anti-gp210 antibody and clinical basic profile of primary billiary cirrhosis].
    Yang J; Yang JH; You LY; Xu ZY; Yang LH
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):468-9. PubMed ID: 19567032
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis.
    Bogdanos DP; Liaskos C; Pares A; Norman G; Rigopoulou EI; Caballeria L; Dalekos GN; Rodes J; Vergani D
    Hepatology; 2007 Jun; 45(6):1583; author reply 1583-4. PubMed ID: 17538935
    [No Abstract]   [Full Text] [Related]  

  • 3. Is prevalence of PBC underestimated in patients with systemic sclerosis?
    Norman GL; Bialek A; Encabo S; Butkiewicz B; Wiechowska-Kozlowska A; Brzosko M; Shums Z; Milkiewicz P
    Dig Liver Dis; 2009 Oct; 41(10):762-4. PubMed ID: 19357001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis.
    Nakamura M; Shimizu-Yoshida Y; Takii Y; Komori A; Yokoyama T; Ueki T; Daikoku M; Yano K; Matsumoto T; Migita K; Yatsuhashi H; Ito M; Masaki N; Adachi H; Watanabe Y; Nakamura Y; Saoshiro T; Sodeyama T; Koga M; Shimoda S; Ishibashi H
    J Hepatol; 2005 Mar; 42(3):386-92. PubMed ID: 15710222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary biliary cirrhosis-specific autoantibodies in patients with systemic sclerosis.
    Mytilinaiou MG; Bogdanos DP
    Dig Liver Dis; 2009 Dec; 41(12):916; author reply 916-7. PubMed ID: 19604733
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anti-Sp100 and anti-Gp210 in the diagnosis of primary biliary cirrhosis in patients with autoimmune cholangitis].
    Romero Gómez M; Wichmann I; Otero Fernández MA; Suárez García E; Grande L; Núñez J; Nevado Santos M; Castro Fernández M
    Gastroenterol Hepatol; 1999 Jan; 22(1):11-3. PubMed ID: 10089705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis.
    Nakamura M; Kondo H; Mori T; Komori A; Matsuyama M; Ito M; Takii Y; Koyabu M; Yokoyama T; Migita K; Daikoku M; Abiru S; Yatsuhashi H; Takezaki E; Masaki N; Sugi K; Honda K; Adachi H; Nishi H; Watanabe Y; Nakamura Y; Shimada M; Komatsu T; Saito A; Saoshiro T; Harada H; Sodeyama T; Hayashi S; Masumoto A; Sando T; Yamamoto T; Sakai H; Kobayashi M; Muro T; Koga M; Shums Z; Norman GL; Ishibashi H
    Hepatology; 2007 Jan; 45(1):118-27. PubMed ID: 17187436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear envelope protein autoantibodies in primary biliary cirrhosis.
    Courvalin JC; Worman HJ
    Semin Liver Dis; 1997 Feb; 17(1):79-90. PubMed ID: 9089913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of autoantibodies against components of the nuclear pore complexes: high frequency of anti-p62 nucleoporin antibodies.
    Wesierska-Gadek J; Klima A; Komina O; Ranftler C; Invernizzi P; Penner E
    Ann N Y Acad Sci; 2007 Aug; 1109():519-30. PubMed ID: 17785341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of autoantibodies against recombinant mitochondrial and nuclear pore proteins after orthotopic liver transplantation for primary biliary cirrhosis.
    Mattalia A; Lüttig B; Rosina F; Leung PS; Van de Water J; Bauducci M; Ciancio A; Böker KH; Worman H; Cooper RL; Manns M; Ansari A; Rizzetto M; Gershwin ME
    J Autoimmun; 1997 Oct; 10(5):491-7. PubMed ID: 9376077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver biopsy in primary biliary cirrhosis: clinicopathological data and stage.
    Drebber U; Mueller JJ; Klein E; Kasper HU; Schulze F; Schardt K; Quasdorff M; Schulte S; Odenthal M; Dienes HP
    Pathol Int; 2009 Aug; 59(8):546-54. PubMed ID: 19627538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative studies of antimitochondrial autoantibodies in sera and bile in primary biliary cirrhosis.
    Nishio A; Van de Water J; Leung PS; Joplin R; Neuberger JM; Lake J; Björkland A; Tötterman TH; Peters M; Worman HJ; Ansari AA; Coppel RL; Gershwin ME
    Hepatology; 1997 May; 25(5):1085-9. PubMed ID: 9141421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of nuclear envelope gp210 antigen in small bile ducts in primary biliary cirrhosis.
    Nakamura M; Takii Y; Ito M; Komori A; Yokoyama T; Shimizu-Yoshida Y; Koyabu M; Matsuyama M; Mori T; Kamihira T; Daikoku M; Migita K; Yatsuhashi H; Nozaki N; Shimoda S; Ishibashi H
    J Autoimmun; 2006 Mar; 26(2):138-45. PubMed ID: 16337775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-mitochondrial antibody-negative primary biliary cirrhosis.
    Selmi C; Zuin M; Bowlus CL; Gershwin ME
    Clin Liver Dis; 2008 Feb; 12(1):173-85, ix. PubMed ID: 18242503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The presentation and diagnosis of 100 patients with primary biliary cirrhosis.
    Sherlock S; Scheuer PJ
    N Engl J Med; 1973 Sep; 289(13):674-8. PubMed ID: 4580473
    [No Abstract]   [Full Text] [Related]  

  • 16. [Meta-analysis of anti-GP210 antibody and anti-SP100 antibody detection for diagnosis of primary biliary cirrhosis].
    Deng HM; Hu SL; Chen WX; Huang Y
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jan; 24(1):62-8. PubMed ID: 26983392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased sensitivity of gp210 autoantibody detection using a newly designed gp210 antigen.
    Xu J; Zhang H; Wang C; Jiang P; Han C; Dai Y; Qiu F; Gong Y; Jiang Y; Xu P; Zhang M; Zhang L; Shi X; Chen S; Tian Y; Seldin MF; Gershwin ME; Liu X; Li L
    J Immunol Methods; 2022 Feb; 501():113211. PubMed ID: 34971632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-gp210 antibodies in sera of patients with primary biliary cirrhosis. Identification of a 64 kD fragment of gp210 as a major epitope.
    Wesierska-Gadek J; Hohenauer H; Hitchman E; Penner E
    Hum Antibodies Hybridomas; 1996; 7(4):167-74. PubMed ID: 9140728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis assessment of GP210 and SP100 for the diagnosis of primary biliary cirrhosis.
    Hu SL; Zhao FR; Hu Q; Chen WX
    PLoS One; 2014; 9(7):e101916. PubMed ID: 25010534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis.
    Liu B; Shi XH; Zhang FC; Zhang W; Gao LX
    Liver Int; 2008 Feb; 28(2):233-9. PubMed ID: 18251980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.